Nektar Therapeutics Inc. (NKTR)
NASDAQ · Healthcare
Nektar Therapeutics Inc. Net Income 2009–2025
Nektar Therapeutics Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Nektar Therapeutics Inc. net income for the quarter ending March 31, 2026 was -44.9 M, a 11.75% decrease year-over-year.
- Nektar Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -172.9 M, a 0.49% increase year-over-year.
- Nektar Therapeutics Inc. annual net income for 2025 was -164.1 M, a 37.92% increase from 2024.
- Nektar Therapeutics Inc. annual net income for 2024 was -119.0 M, a 56.91% decrease from 2023.
- Nektar Therapeutics Inc. annual net income for 2023 was -276.1 M, a 25.03% decrease from 2022.
- Nektar Therapeutics Inc. annual net income for 2022 was -368.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Nektar Therapeutics Inc. Net Income — FAQ
Nektar Therapeutics Inc. (NKTR) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Nektar Therapeutics Inc.'s net income?
Nektar Therapeutics Inc. (NKTR) reported net income of -$164M for fiscal 2025.
Where can I see NKTR's net income history?
The chart and table above show Nektar Therapeutics Inc.'s net income by year and by quarter, including the growth rate.